Skip to content
Review Open access

Pericoronary Adipose Tissue Imaging on Coronary CT Angiography: From Fat Attenuation Index to Radiomic Risk Phenotyping

Jan 2026 · BioMed Research International · Vol 2026 · 0 citations · 28 references
Medicine

TL;DR

A vendor‐neutral reporting and validation framework is proposed and PCAT biomarkers are position as complementary to coronary calcium, stenosis, plaque phenotype, CT‐derived physiology, and artificial intelligence–assisted risk stratification rather than as a hierarchy of prognostic tests.

Abstract

Coronary computed tomography angiography (CCTA) has evolved from an anatomical test into a platform for cardiovascular risk phenotyping. Pericoronary adipose tissue (PCAT), which is directly contiguous with the coronary adventitia, changes its composition in response to vascular inflammation and can be interrogated on routine CCTA. Importantly, PCAT attenuation, the fat attenuation index (FAI), and the standardized FAI score are related but nonequivalent measurements: Raw PCAT attenuation is a mean Hounsfield unit measurement within a defined PCAT region, whereas FAI denotes an attenuation‐based methodological construct and FAI score is a standardized, vessel‐specific output adjusted for technical, biological, and anatomical factors. Radiomics extends assessment beyond attenuation by extracting multivariable intensity, shape, and texture features. Selected radiotranscriptomically validated features within the fat radiomic profile (FRP) have been linked to fibrosis and vascularity, but this biological interpretation should not be generalized to all PCAT radiomic signatures. Outcome studies demonstrate clinically relevant associations for attenuation‐based and radiomic biomarkers, although effect sizes, incremental value, and validation differ across populations and analytic platforms. Translation is limited by retrospective evidence, acquisition and reconstruction heterogeneity, lack of universal raw‐attenuation cutoffs, dependence of some standardized outputs on proprietary software, and limited prospective outcome‐driven validation. This narrative review synthesizes the biological rationale, terminology, clinical evidence, technical reproducibility, and emerging technologies in PCAT imaging. We propose a vendor‐neutral reporting and validation framework and position PCAT biomarkers as complementary to coronary calcium, stenosis, plaque phenotype, CT‐derived physiology, and artificial intelligence–assisted risk stratification rather than as a hierarchy of prognostic tests.

Read PDF

Similar papers

Open access Sep 2026

Incremental diagnostic value of coronary CT angiography-derived pericoronary adipose tissue radiomics for identifying hemodynamically significant coronary stenosis

Background Pericoronary adipose tissue (PCAT) radiomics may complement coronary computed tomography angiography (CCTA)-based anatomical and physiological assessment. This study aimed to evaluate its incremental diagnostic value for identifying hemodynamically significant coronary stenosis. Methods This retrospective st...

Wei Fan, Hong-Xuan Wang, Bai-Hui Zhang et al. · 0 citations
Open access Oct 2026

Pericoronary adipose tissue imaging biomarkers (PCAT, FAI) in normal-weight, overweight, and obese patients with CAD-RADS 0

Vascular inflammation is a key driver of atherosclerosis and plaque instability, leading to major adverse cardiac events (MACE). Although a coronary artery calcium (CAC) score of zero indicates a very low likelihood of obstructive CAD on coronary computed tomography angiography (CCTA), low-attenuation noncalcifie...

M. Słaboszewski, J. Szachowicz-Jaworska, J. Nessler et al. · 0 citations
Open access Oct 2026

Perivascular fat attenuation index improves the identification of functional myocardial ischemia beyond traditional risk factors: a coronary CT angiography-derived fractional flow reserve study

Coronary perivascular FAI is an independent imaging marker for CT-FFR-defined functional ischemia and provides incremental value beyond traditional risk factors and EAT volume, support FAI as a non-invasive marker of coronary inflammation that may refine risk stratification for functionally significant coronary artery...

Zhi-Hong Gao, Lin-Hui Jia, Min Jia · 0 citations
Open access Sep 2026

Association between lesion-specific fat attenuation index and high-risk plaque on coronary computed tomography angiography

Objective To investigate the association between lesion-specific fat attenuation index (FAI) derived from coronary computed tomography angiography (CCTA) and CCTA-defined high-risk plaque (HRP). Methods A total of 560 patients undergoing CCTA for the first time who had at least one evaluable coronary atherosclerotic le...

Zhi-Kun Chen, Jun-Mei Zhao, Ya-Yun Liu et al. · 0 citations
Open access Oct 2026

Association between the perivascular fat attenuation index and CCTA-defined anatomically significant left anterior descending coronary artery stenosis: relationship with serum inflammatory biomarkers

Objective To investigate whether lesion-specific perivascular fat attenuation index (FAI) is associated with CCTA-defined anatomically significant (≥50%) left anterior descending coronary artery (LAD) stenosis and to evaluate the diagnostic performance of a composite model integrating serum inflammatory biomarkers. Met...

Yiliya Ahongjiang, Alimujiang Abudukaiyoumu, Gulinuer Abulimiti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.